Hirano, Daiki
Hayakawa, Fumihiko
Yasuda, Takahiko
Tange, Naoyuki
Yamamoto, Hideyuki
Kojima, Yuki
Morishita, Takanobu
Imoto, Naoto
Tsuzuki, Shinobu
Mano, Hiroyuki
Naoe, Tomoki
Kiyoi, Hitoshi
Article History
Received: 9 November 2017
Revised: 29 August 2018
Accepted: 11 October 2018
First Online: 26 November 2018
Compliance with ethical standards
:
: HK received research funding from Chugai Pharmaceutical Co., Ltd., Bristol-Myers Squibb, Kyowa-Hakko Kirin Co., Ltd., Zenyaku Kogyo Co., Ltd., FUJIFILM Corporation, Nippon Boehringer Ingelheim Co., Ltd., Astellas Pharma Inc., and Celgene Corporation, consulting fees from Astellas Pharma Inc. and Daiichi Sankyo Co., Ltd., and honoraria from Bristol-Myers Squibb and Pfizer Japan Inc. The remaining authors declare that they have no conflict of interest.